Introduction
============

Antimicrobial usage (AMU) is considered an important driver for the selection of antimicrobial resistance (AMR) in human, animal and environmental bacteria.[@dkz235-B1] AMR in pathogenic bacteria hampers treatment and results in increased healthcare costs.[@dkz235-B2] Next to human healthcare, one of the main users of antimicrobials is the intensive livestock industry. Resistance development in livestock is a great concern for the animal population and could be a source of bacteria transferring AMR to the human population.[@dkz235-B3]

Broiler production is a major industry within livestock farming.[@dkz235-B4] Broilers are produced in a highly optimized way, characterized by a pyramidal structure consisting of a small number of pedigree and great-grandparent stock farms at the top of the pyramid and a large number of broiler farms at the bottom.[@dkz235-B5] Broilers are raised for consumption within 6--7 weeks on average, which results in over 10 million tons of chicken meat produced in 2014 in the EU.[@dkz235-B6] In these conditions, antimicrobials are regularly administered to the whole flock to prevent or control infectious diseases.[@dkz235-B7]^,^[@dkz235-B8]

In Europe, AMU in broiler production is mostly reported at country level and based on national sales-data monitoring systems. When national sales data are related to national AMR data, mostly based on MIC determinations for the bacterial indicator *Escherichia coli*, positive associations have been observed for several antimicrobial classes.[@dkz235-B1]^,^[@dkz235-B9]^,^[@dkz235-B10] Evidence beyond these 'ecological' associations is limited due to the absence of more detailed epidemiological data within countries and species at the farm level. Research at farm or even flock level enables analysis of such relationships in the same epidemiological unit and allows adjustment for potential confounding variables, which are generally not available for country-level analyses and might potentially lead to ecological fallacy.[@dkz235-B11]^,^[@dkz235-B12] For broilers, only a few association studies have been performed at farm level. These studies provide evidence for a positive association between flock- or farm-level AMU and AMR in specific commensal or pathogenic bacteria.[@dkz235-B13]^,^[@dkz235-B14]

One possibly related (risk) factor or confounder that can be addressed with farm- or flock-level data is farm biosecurity. Farm biosecurity has been defined as the total of all measures taken to prevent both introduction and spread of infectious agents[@dkz235-B15] and thus represents a collection of many potential factors that might influence introduction and further spread of AMR.[@dkz235-B13]^,^[@dkz235-B14]^,^[@dkz235-B16]

In this study, metagenomic shotgun sequencing is applied for the analysis of the resistome, in DNA from the total community of faecal bacteria. Metagenomic sequencing enables a broad, culture-independent and semi-quantitative reflection of resistance present in a broiler flock.[@dkz235-B17] The aim of this study was to determine the relationship between the broiler faecal resistome and farm- and flock-level usage of antimicrobials and farm biosecurity status in nine European countries.

Materials and methods
=====================

Study design
------------

This cross-sectional study relates potential risk factors to the resistome of a pooled faecal sample from one flock of each broiler farm. In total, 181 flocks from 181 farms from nine European countries (Belgium, Bulgaria, Denmark, France, Germany, Italy, the Netherlands, Poland and Spain) were sampled. In this paper, samples from 176 of the 181 farms were included. Five samples were excluded due to errors made during processing or incomplete data. All farms have been anonymized to ensure that results cannot be traced back to individual farms. Country was anonymized as this was required by the farming organization in one participating country.

Selection of farms and sampling
-------------------------------

In the nine collaborating countries, 20 non-mixed conventional broiler farms per country were visited between May 2014 and June 2016. Eligible farms needed to have, among other criteria, all-in all-out production (thinning from day 30 onwards allowed), no intended slaughter age higher than 50 days and no production of animals other than broilers. Further farm characteristics and (country-specific) deviations from the selection protocol can be found in the supplement of Munk *et al*.[@dkz235-B18] Per farm, 25 fresh faecal droppings from the floor from one flock (one batch) were collected, transported at 4°C and stored at −80°C within 24 hours. In this study a pooled sample of the 25 individual samples was used, resulting in one faecal pool per flock and per farm.

Laboratory analysis and bioinformatics analysis
-----------------------------------------------

After DNA extraction and metagenomic shotgun sequencing (Illumina HiSeq 3000, 50 million paired-end reads per sample), the cleaned reads were mapped to the ResFinder antimicrobial resistance gene (ARG) database (accessed 17 November 2016) of the Centre for Genomic Epidemiology.[@dkz235-B19] The output was clustered at an ARG sequence identity level of 90%. The unit of outcome is a normalized read count FPKM (fragments per kb reference per million bacterial fragments). FPKM was calculated by dividing the mapped resistance fragments by the length of the respective resistance gene and the total number of bacterial fragments per sample and multiplying by 10^9^. In the analyses, the following outcomes per flock were used: (i) the sum of FPKM of all resistance gene clusters; (ii) the sum of FPKM per antimicrobial class; and (iii) the FPKM per 90% identity-level gene cluster for two antimicrobial classes.

More details on the laboratory analysis and metagenomic shotgun sequencing can be found in the [Supplementary Methods](#sup1){ref-type="supplementary-material"} (available as [Supplementary data](#sup1){ref-type="supplementary-material"} at *JAC* Online) and in Munk *et al*.[@dkz235-B18]

Quantification of AMU and farm biosecurity
------------------------------------------

Information on AMU, biosecurity status and several other characteristics of the farm and flock was collected through a questionnaire by interviewing the farmer on the day of the visit. The quantification of AMU is described in detail by Joosten *et al*.[@dkz235-B7] Two measures of AMU have been derived: (i) antimicrobials administered via group treatment to the flock from which the samples were taken (during its lifespan until sampling close to the age of slaughter); and (ii) antimicrobials purchased for the whole farm (which may contain more flocks than the sampled flock) in the year before sampling. The treatment incidence (TI) of DDDs (TIDDDvet) was calculated by dividing the amount of antimicrobials administered or purchased by the dose multiplied by days at risk multiplied by kg of animal. TIDDDvet can be read as the percentage of the life of a broiler for which it is treated. In the analyses, the following explanatory variables were used: (i) the total sum of TIDDDvet per flock (group treatment data) or farm (purchase data); and (ii) the sum per antimicrobial class.

The questionnaire also contained items relevant for the calculation of the biosecurity score with the Biocheck.Ugent method.[@dkz235-B16] More details are provided in the [Supplementary Methods](#sup1){ref-type="supplementary-material"}. The biosecurity score is expressed as a value between 0 (no biosecurity measures are in place) and 100% (all biosecurity measures are in place and used). In the analyses, the external and internal biosecurity scores were tested as explanatory variables.

Data analysis
-------------

A country effect appears in both AMR and AMU data and has been described before.[@dkz235-B7]^,^[@dkz235-B18] For example, the country of origin of the samples is significantly associated with the resistome and explains roughly 25% of the variation observed. To address this effect, considering the total number of farms per country included in the analysis (18 or 20), we used country-specific models as input for a random-effects meta-analysis (R package Metafor, DerSimonian-Laird heterogeneity estimator).[@dkz235-B20] Meta-analysis allows results to be obtained and visualized in a transparent way.[@dkz235-B21] Outcome and AMU data were log~10~ transformed because of skewness (1 was added to keep zeros), and the outcome was standardized (mean 0, SD 1). Thus, associations were first calculated with linear regression per country and subsequently a meta- or overall association was calculated across countries. Concurrent usage and observations of the corresponding resistance did not occur at all farms and occasionally not in each country, resulting in specific meta-analyses with data from fewer than nine countries. The analysis was performed stepwise: first the association between AMU and ARGs was calculated for each corresponding antimicrobial class (e.g. tetracycline resistance versus tetracycline use), followed by non-corresponding classes. Confounding by biosecurity status of the farm and sampling age of the broilers was tested. A sensitivity analysis was performed by calculating the association between corresponding ARGs and AMU as a binary variable, with 0 meaning no AMU reported at flock or farm level and 1 meaning (any) AMU reported at flock or farm level.

The same meta-analysis approach was used to test the association between ARGs and internal and external biosecurity status, with and without adjusting for AMU. For two antimicrobial groups that showed a robust association with corresponding ARGs, an additional analysis was performed to test which gene clusters drive the association with the respective antimicrobial class. Again, random-effects meta-analysis was used with individual gene clusters as the outcome and corresponding AMU as the explanatory variable.

To control for multiple testing we applied a false discovery rate (FDR) of 0.1, using the Benjamini--Hochberg procedure.[@dkz235-B22] This was done separately for the six analyses described above. All descriptive and statistical analyses were done in R (version 3.3.1).[@dkz235-B23] An explanation of the interpretability of our results can be found in the [Supplementary Methods](#sup1){ref-type="supplementary-material"}.

Data availability
-----------------

The DNA sequences (reads) from 363 metagenomic samples from 359 herds are deposited in the European Nucleotide Archive under the project accession number PRJEB22062.

Results
=======

Farms
-----

The average flock size at setup over all nine countries was 27971 one-day-old chicks (Table [1](#dkz235-T1){ref-type="table"}). On average, the smallest flocks were sampled in country I (16413 one-day-old chicks) and the largest flocks in country C (35035 one-day-old chicks). Age of sampled flocks was 34 days on average, with the youngest broilers sampled in country C (26 days) and the oldest in country D (42 days). The average weight at slaughter of the broilers from the sampled farms was 2372 g (range: 1744 g in country E to 2693 g in country H).

###### 

General characteristics of the sampled farms and flocks by country and overall countries

  Country    Number of farms included in the analyses   Average number of broilers present at the farm   Average number of rounds per year   Number of broilers set up in the sampled barn   Age of broilers during sampling (days)   Average weight of broilers during sampling (g)   Average weight of broilers at slaughter (g)                                   
  --------- ------------------------------------------ ------------------------------------------------ ----------------------------------- ----------------------------------------------- ---------------------------------------- ------------------------------------------------ --------------------------------------------- ------ ---- ------ ------ ------ ------
  A                             20                                          77322                                      80000                                       7                                           7                                          29952                                           28300                       34    35   2042   2125   2529   2500
                                                                       (24530--180000)                                (3--8)                                (16500--46700)                                  (27--39)                                   (1300--2490)                                   (2385--2750)                                                   
  B                             18                                          106059                                     76600                                       8                                           8                                          29827                                           32750                       31    33   1861   1900   2320   2400
                                                                       (17200--240000)                              (7.3--8.5)                              (17200--41400)                                  (19--40)                                   (1350--2700)                                   (1550--2700)                                                   
  C                             20                                          46255                                      35150                                       8                                           8                                          35035                                           34450                       26    27   1361   1322   2236   2193
                                                                       (25000--144000)                               (7--8.5)                               (25000--53300)                                  (16--32)                                   (530--2000)                                    (2000--2800)                                                   
  D                             20                                          96390                                      60000                                       5                                           5                                          23398                                           20950                       42    43   2440   2450   2645   2600
                                                                       (24000--400000)                               (4--5.5)                               (11340--50000)                                  (34--51)                                   (1600--3650)                                   (2100--3700)                                                   
  E                             20                                          54810                                      47500                                       6                                           6                                          30605                                           29580                       31    29   1479   1214   1744   1625
                                                                       (21400--216000)                                (3--9)                                (21420--42886)                                  (21--48)                                   (575--3000)                                    (1300--2700)                                                   
  F                             20                                          108258                                    110000                                       7                                           7                                          30849                                           31200                       36    36   1939   1940   2375   2388
                                                                       (32000--200000)                               (6--8.5)                               (17550--49700)                                  (29--42)                                   (1500--2500)                                   (2065--2721)                                                   
  G                             20                                          56135                                      41500                                       6                                           6                                          31473                                           33565                       36    36   2009   2070   2528   2500
                                                                       (19000--150000)                                (5--6)                                (18500--41800)                                  (30--42)                                   (1300--2500)                                   (2050--2900)                                                   
  H                             20                                          41680                                      30210                                       5                                           6                                          23219                                           22440                       36    37   1907   1900   2693   2750
                                                                       (20000--114141)                               (2--6.5)                               (14000--33864)                                  (22--44)                                   (859--2500)                                    (1750--3000)                                                   
  I                             18                                          54873                                      20000                                       6                                           6                                          16413                                           16725                       31    29   1529   1645   2264   2200
                                                                        (8000--250000)                                (4--7)                                 (8000--27000)                                  (19--54)                                   (730--2600)                                    (1950--2700)                                                   
  Overall                      176                                          71101                                      50000                                     6.35                                         6.15                                        27971                                           26500                      33.8   34   1844   1850   2372   2450
                                                                        (8000--400000)                                (2--9)                                 (8000--53300)                                  (19--54)                                   (575--3650)                                    (1300--3700)                                                   

Associations between usage and resistance
-----------------------------------------

Of the 176 analysed flocks, 66 (38%) did not report any use of group treatments in the sampled flock up to the day of sampling. In total, 22 farms (13%) reported not to have purchased any antimicrobials in the year before sampling. Most of the non-users (47 of 66) were present in three countries (C, F and I) However, these untreated flocks showed similar diversity and only slightly reduced ARG clusters (overall mean of 1677 FPKM) compared with treated flocks (overall mean of 1880 FPKM) (Figure [1](#dkz235-F1){ref-type="fig"}a and b).

![(a) Mean sum of ARGs in FPKM of farms that did or did not report AMU in group treatments for the sampled flock, grouped by country. Left: total ARGs versus total AMU per flock with number of farms shown above the bars. Right: ARGs of several (handpicked) antimicrobial classes/groups versus corresponding AMU per flock with number of farms shown above the bars. (b) Mean sum of ARGs in FPKM of farms that did or did not report AMU in purchased products by the whole farm in the year before sampling, grouped by country. Left: total ARGs versus total AMU per farm with number of farms shown above the bars. Right: ARGs of several (handpicked) antimicrobial classes/groups versus corresponding AMU per farm with number of farms shown above the bars.](dkz235f1){#dkz235-F1}

Both possible confounders (farm biosecurity and sampling age of the broilers) were not significantly associated with the outcome and, when added to the models, estimates of the associations did not change more than 10%. Therefore, these variables were not included in the final and presented models. For discussion of our results we applied an FDR of 0.1; the FDR per comparison is given in all tables.

Although high levels of resistance were present in flocks or farms without AMU in the sampled rearing period, we did find associations between AMU and the corresponding ARGs (Table [2](#dkz235-T2){ref-type="table"}). Significant positive associations were found between flock group treatments and ARGs for MLS antibiotics (macrolides, lincosamides and streptogramins), tetracyclines, aminoglycosides, β-lactams (Figure [2](#dkz235-F2){ref-type="fig"}a) and trimethoprim and their respective resistance. MLS antibiotics used included macrolide and lincosamide treatments. The MLS resistance group included macrolide, lincosamide and streptogramin gene clusters.

![Two example forest plots of the country-specific associations and meta-analysis results. Left: β-lactam ARGs in FPKM and β-lactam group treatments as TIDDDvet. Right: MLS ARGs (FPKM) and purchased MLS products (TIDDDvet). The number of farms that report AMU, the weight of the individual association in the summary estimate and the 95% CI per country are also shown. The summary estimates with confidence intervals for the overall association are shown at the bottom.](dkz235f2){#dkz235-F2}

###### 

Results of meta-analysis between ARGs in FPKM and AMU as TIDDDvet of corresponding antimicrobial classes/groups

  Class/group of ARGs                               Class/group of AMU[^a^](#tblfn2){ref-type="table-fn"}   Estimate   *P* value     FDR           95% CI                  Country and number of farms with reported AMU
  ------------------------------------------------- ------------------------------------------------------- ---------- ------------- ------------- ----------------- ---------------------------------------------------------
  **MLS (macrolide, lincosamide, streptogramin)**   **MLS (macrolide, lincosamide) (group)**                **1.18**   **\<0.001**   **\<0.001**   **0.74--1.62**              **A-8, B-5, C-1, D-4, G-3, H-3, I-1**
  **Tetracycline**                                  **tetracycline (group)**                                **0.98**   **\<0.001**   **\<0.001**   **0.57--1.39**                **A-6, B-2, C-2, F-1, G-8, H-1**
  **Trimethoprim**                                  **trimethoprim/sulphonamide (purchased)**               **1.19**   **0.004**     **0.026**     **0.37--2.01**            **A-11, B-9, C-1, D-16, E-7, F-16, G-9**
  **Tetracycline**                                  **tetracycline (purchased)**                            **0.83**   **0.005**     **0.026**     **0.25--1.41**        **A-13, B-1, C-2, D-1, E-1, F-8, G-13, H-1, I-4**
  **Total**                                         **total (purchased)**                                   **0.58**   **0.008**     **0.028**     **0.15--1.00**     **A-20, B-18, C-5, D-20, E-19, F-20, G-20, H-17, I-15**
  **MLS (macrolide, lincosamide, streptogramin)**   **MLS (macrolide, lincosamide) (purchased)**            **1.17**   **0.008**     **0.028**     **0.30--2.04**       **A-18, B-14, C-3, D-13, E-6, F-5, G-7, H-3, I-5**
  **Amphenicol**                                    **amphenicol (purchased)**                              **7.76**   **0.016**     **0.045**     **1.47--14.04**                       **D-2, G-2, I-1**
  **β-Lactam**                                      **β-lactam (group)**                                    **0.38**   **0.025**     **0.058**     **0.05--0.72**          **A-10, B-3, D-15, E-9, F-1, G-10, H-6, I-1**
  **Trimethoprim**                                  **trimethoprim/sulphonamide (group)**                   **0.86**   **0.026**     **0.058**     **0.10--1.61**                  **A-4, D-11, E-5, F-3, G-2**
  **Aminoglycoside**                                **aminoglycoside (group)**                              **1.23**   **0.031**     **0.063**     **0.11--2.35**                          **G-2, H-7**
  **Aminoglycoside**                                **aminoglycoside (purchased)**                          **1.04**   **0.047**     **0.086**     **0.01--2.07**                          **G-4, H-7**
  Sulphonamide                                      trimethoprim/sulphonamide (purchased)                   0.72       0.106         0.177         −0.15--1.59                 A-11, B-9, C-1, D-16, E-7, F-16, G-9
  Total                                             total (group)                                           0.33       0.207         0.319         −0.18--0.85           A-18, B-11, C-3, D-19, E-16, F-5, G-19, H-16, I-3
  Sulphonamide                                      trimethoprim/sulphonamide (group)                       0.47       0.238         0.340         −0.31--1.26                       A-4, D-11, E-5, F-3, G-2
  Amphenicol                                        amphenicol (group)                                      1.10       0.266         0.354         −0.84--3.04                                  G-1
  β-Lactam                                          β-lactam (purchased)                                    0.30       0.298         0.373         −0.26--0.86             A-20, B-15, D-20, E-16, F-18, G-14, H-10, I-1
  Polymyxin                                         polymyxin (purchased)                                   −0.07      0.668         0.786         −0.38--0.24                 B-14, D-18, E-7, F-2, G-11, H-4, I-1
  Quinolone                                         quinolone (purchased)                                   0.20       0.738         0.820         −0.96--1.36              A-15, B-4, D-16, E-17, F-8, G-20, H-7, I-8
  Quinolone                                         quinolone (group)                                       −0.02      0.915         0.964         −0.41--0.36               A-7, B-1, D-6, E-10, F-1, G-16, H-7, I-2
  Polymyxin                                         polymyxin (group)                                       0.00       0.987         0.987         −0.35--0.35                        B-2, D-9, E-3, G-6, H-4

Associations in bold have a false discovery rate \<0.1.

(group) indicates AMU in group treatments of the sampled flock; (purchased) indicates AMU in purchased products by the farm in the year before sampling.

For AMU defined as products purchased by the whole farm, significant associations were found for total, MLS antibiotics (Figure [2](#dkz235-F2){ref-type="fig"}b), tetracycline, amphenicol and trimethoprim products and their respective resistance. The analysis between corresponding resistance and AMU as a binary variable gave the same results as the analysis with AMU as a continuous variable except for the association with total purchased products (Table [S1](#sup1){ref-type="supplementary-material"}).

To investigate co- or cross-resistance, associations between total ARGs or ARGs per antimicrobial class and total and non-corresponding usage or purchased products were tested. After controlling for the FDR, none of these associations remained significant (Table [S2](#sup1){ref-type="supplementary-material"}).

The resistance reported per antimicrobial class is the sum of FPKM of many different resistance gene clusters. For most classes the contribution of single resistance gene clusters to the overall class-level ARG is highly skewed (with a few genes largely determining the sum of ARG per class) (Table [3](#dkz235-T3){ref-type="table"}). A detailed analysis was performed of the association between β-lactam group treatments and individual β-lactam resistance gene clusters and between purchased MLS products and MLS resistance gene clusters (Tables [S3 and S4](#sup1){ref-type="supplementary-material"}). Within both of these antimicrobial classes/groups we observed a significant positive association with the most abundant gene cluster \[*bla*~TEM~ and *erm*(B), respectively\]. For β-lactam group treatments the only other significant positive association was with the *bla*~ACT~ cluster. For purchased MLS products we also saw significant positive associations with several different *erm* gene clusters and *lsaA and mefB.*

###### 

Ten most abundant gene clusters per antimicrobial class/group (which gave an overall significant association with AMU) and their contribution to the total sum of ARGs in percentages

  Rank                 β-Lactam                \%         MLS     \%        Aminoglycoside    \%       Tetracycline  \%       Amphenicol  \%         Trimethoprim     \%
  ------ ------------------------------------- ------- ---------- ------- ------------------- ------- -------------- ------- ------------ ------- ------------------- -------
  1                   *bla* ~TEM~              84.65    *erm*(B)  41.11    *aadA* cluster 1   23.06      *tet*(W)    57.35      *cmx*     29.90         *dfrA1*       47.50
  2       *bla* ~CMY~--*bla*~BIL~--*bla*~LAT~  2.43     *lnu*(A)  21.65          *spc*        12.73      *tet*(A)    8.67     *catpC194*  23.49         *dfrD*        15.34
  3                   *bla* ~SHV~              1.70     *lnu*(C)  17.97         *strB*        10.50      *tet*(L)    6.71       *cml*     16.25         *dfrK*        7.90
  4                 *bla* ~OXA-61~             1.67     *erm*(C)  3.80     *aadE* 1 KF864551  9.78       *tet*(M)    6.06       *floR*    12.92        *dfrA12*       7.14
  5                  *bla* ~ACT-9~             1.65     *erm*(X)  2.40          *strA*        9.27       *tet*(Q)    3.55      *catA1*    5.26         *dfrA14*       5.17
  6                   *bla* ~ACT~              1.43     *vat*(E)  1.86        *aph3* III      8.15       *tet*(Z)    2.94       *cat3*    2.71          *dfrG*        4.35
  7                     *cfxA*                 1.35     *erm*(F)  1.59         *ant6* Ia      3.24       *tet*(O)    2.66       *cat2*    1.64         *dfrA16*       3.39
  8             *bla* ~CTX-M~ cluster 1        1.26     *lnu*(B)  1.49        *aac3* Iva      3.08       *tet*(4)    1.92       *cat*     1.51     *dfrA7*--*dfrA17*  3.25
  9                     *cepA*                 0.59     *erm*(G)  0.95         *aph4* Ia      2.98       *tet*(B)    1.75       *fexA*    1.17         *dfrA15*       2.96
  10               *mecA* cluster 1            0.53     *lnu*(F)  0.91     *aadE* 1 KF421157  2.98      *tet*(33)    1.51     *catpC221*  1.06     *dfrA5*--*dfrA30*  1.90

Biosecurity
-----------

We found two statistically significant associations between ARGs (analysed in total and per class) and internal or external biosecurity (Table [S5](#sup1){ref-type="supplementary-material"}). We observed a significant, positive association between oxazolidinone resistance and internal biosecurity (i.e. higher internal biosecurity is associated with more oxazolidinone resistance genes) and a significant, negative association between tetracycline resistance and internal biosecurity. After adjustment for AMU, only the former association remained.

Discussion
==========

In this study we quantified resistance using the resistome of pooled faecal flock samples obtained by metagenomic analysis and related this to AMU data of the broiler flocks and farms from different countries. Our results confirm the hypothesis that higher antimicrobial exposure at flock or farm level is associated with more AMR.

Positive associations between AMU and ARGs
------------------------------------------

Our AMR and AMU data showed country-specific differences[@dkz235-B7]^,^[@dkz235-B18] and therefore random-effects meta-analysis was used to test the relationship between ARGs and AMU. Almost all associations between ARGs and AMU of corresponding antimicrobial classes were positive. The abundance of genes coding for tetracycline, MLS, trimethoprim and aminoglycoside resistance was significantly positively related to the corresponding flock treatments and corresponding products purchased by the farm. Our data thus showed that current use in a flock is associated with a higher abundance of resistance genes in the same flock, although antimicrobial products from these classes have been used in broilers for a long time now. An increase in several *tet* genes and the use of chlortetracycline has also been shown by others.[@dkz235-B24] In the frequent---and expected---case that not all classes of antibiotics were used in a specific flock in its lifespan, when this occurred countrywide this country was not included in the meta-analysis. The results per antibiotic class were therefore often based on fewer than nine countries. β-Lactams, quinolones and polymyxins were the classes used most in this study.[@dkz235-B7] For quinolones and polymyxins, no significant relation was found with their corresponding ARGs. For polymyxins, this is probably due to relatively low gene abundances in the samples (Figure [1](#dkz235-F1){ref-type="fig"}). For quinolones, usage is reported in almost all countries and an association with resistance has been described before (though not with metagenomic analysis).[@dkz235-B13]^,^[@dkz235-B25] One likely reason for this lack of association is that quinolone resistance is partly due to point mutations that could not be detected sufficiently with the resistance gene database used here, and is difficult to detect in metagenomic studies altogether.[@dkz235-B26] The association between β-lactam resistance and use in the sampled flock was significant in our study. Within the class of β-lactam resistance, *bla*~TEM~ turned out to be the gene cluster with the highest FPKM, in agreement with the significant positive association between *bla*~TEM~ and β-lactam use in the flock. The *bla*~TEM~ cluster is large: it includes \>150 TEM-type β-lactamases,[@dkz235-B18] of which a large part have an ESBL- or inhibitor-resistant phenotype. Genes of special interest, such as *bla*~CTX-M~ and *bla*~CMY~, were observed in these flocks. Probably due to the fact that these genes were restricted to relatively rare species and that usage of the respective antibiotics was low, we did not find significant associations. Within the MLS gene cluster, there were a number of genes that were significantly positively associated with MLS products purchased by the farm in the year before sampling, including not only the expected highly abundant gene clusters *erm*(B) and *erm*(C), but also less prevalent genes. All in all, we conclude that higher reported AMU is associated with higher relative gene abundance, while the resulting veterinary and public health implications are yet difficult to conclude upon.

Flock- versus farm-level AMU
----------------------------

Our results show a similar, but not identical, picture of associations between ARGs and usage at flock level (use in the sampled flock specifically) as for usage at farm level (purchased products over one year). Flock-level data are considered to be superior to data on purchased products if associations between AMU and AMR are thought to occur by selection in the actual flock. The overall correlation between TIDDDvet of group treatments and purchased products over one year is moderate (0.54[@dkz235-B7]) and data on these purchased products might resemble general and/or historic use by the farm and thereby give an additional perspective on the association between usage and resistance, which might also occur through recirculation of resistant bacteria within a farm from flock to flock. Moreover, the presence of residual amounts of antimicrobials might be sufficient to maintain the presence of resistant bacteria.

ARGs without current antimicrobial pressure
-------------------------------------------

Overall, the observed positive associations between ARG and AMU were relatively weak, and the presence of many of the measured resistance genes seems not to be explained by current use. This can also be concluded from the roughly similar abundance of resistance genes in the flocks and farms that do not report any AMU. Several reasons for resistance genes being present without current antimicrobial pressure have been suggested in the literature. Roughly since the 1950s, increasing amounts and types of antimicrobials have been used in the livestock industry exerting selective pressures on the development and spread of AMR.[@dkz235-B27] Also, usage in other (higher) sections of the broiler pyramid might influence AMR in lower sections through vertical transmission.[@dkz235-B5]^,^[@dkz235-B28]

Once resistance genes are present at a farm, recirculation of resistance genes via the (farm) environment is possible.[@dkz235-B29]^,^[@dkz235-B30] Furthermore, resistance gene carriage does not necessarily compromise microbial fitness, which makes presence of resistance genes in the absence of AMU pressure more likely.[@dkz235-B31]^,^[@dkz235-B32] Taken together, the drivers for resistance genes to be present in poultry samples are diverse, complicating quantification of the associations between AMU and AMR. From these results, it can also be questioned to what extent resistance can be reduced only through reducing the use in specific flocks.

Biosecurity
-----------

External and internal biosecurity include all possible measures to minimize the introduction and spread of disease at the farm. Possibly, the introduction and spread of ARGs could also be influenced by these measures. No data exist on the association between internal and external biosecurity scores and AMR yet, but associations with a few individual measures have been reported.[@dkz235-B14]^,^[@dkz235-B33] Within the EFFORT study, the same associations have been explored within European pig farming. This resulted in a positive association between internal biosecurity and macrolide gene clusters.[@dkz235-B21] Our analysis, after adjusting for AMU, resulted in one association: higher internal biosecurity was associated with a higher relative abundance of oxazolidinone ARGs. Oxazolidinone antibiotics are not used in broiler production though and we do not have an explanatory hypothesis for this specific association. Due to the limited degree of association overall, we conclude that our data are not sufficient to support the hypothesis that introduction and spread of ARGs is influenced by biosecurity measures.

Co- or cross-resistance
-----------------------

The analysis of the relationship between non-corresponding antimicrobial classes of resistance and use did not result in significant associations. The analysis was based on short metagenomics reads, which implies that the actual origin and genomic context is unknown, hindering focused searches for co- or cross-resistance within one species or genomic context. However, within the data generated in this study, the role of co- or cross-resistance is minor compared with usage of the corresponding class.

Strengths and limitations of the study
--------------------------------------

With 176 broiler flocks included in these analyses this is, to our knowledge, the largest metagenomic cross-country study that has been performed in poultry, which enabled us to look at the whole faecal resistome instead of specific resistance in specific bacteria. Despite this large number of samples, insufficient power might still be a reason for not detecting certain associations in our study. Although sampling was performed in nine countries, all information concerning AMU and biosecurity was collected in a harmonized way with the use of protocols and close collaboration between the researchers. Despite this, bias might be introduced by misclassification of biosecurity and underreporting of AMU. Bias might also be introduced by the DNA extraction procedure and the library preparation. It often favours certain bacteria, thereby biasing retrieved gene frequencies; however, this bias should be consistent across all samples and countries. The current selection of farms in each country is based on preset inclusion criteria and in agreement with local farming organizations, and partially also based on convenience (e.g. distances to farms). As a result, the sample of farms in each country cannot be considered representative for the livestock sector in that country.

With respect to the methodology, another limitation of the focus on similarity of short reads to known resistance genes is that the function of the assumed resistance genes can only be assigned with a certain probability and it is unknown whether their presence implies functional/expressed resistance. However, it has been shown that tetracycline resistance measurements in the same sample in cfu counting of aerobic bacteria and metagenomics do correlate significantly.[@dkz235-B34] Another limitation is the fact that due to the large but still limited sequencing depth relatively rare genes might be underrepresented in the results. Also, resistance genes from unculturable bacteria are probably underrepresented in the ResFinder database and therefore in our analysis.

Conclusions
-----------

This study applied metagenomics to establish associations between AMU and the resistome on European broiler farms. Clearly positive associations between corresponding AMU and resistance genes were observed. Significant results were shown for both flock-level and farm-level usage, highlighting that both actual and historic use can contribute to AMR presence. Our data did not support associations with ARGs and non-corresponding AMU or biosecurity status of the farm. We do, however, show that the faecal microbiome harbours many resistance genes in the absence of current AMU.

Supplementary Material
======================

###### 

Click here for additional data file.

Parts of the results have been presented orally at the 5th International One Health Congress in Saskatoon, Canada, June 2018 (abstract number 4 AMR 02).
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